Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vancomycin toxicity: a prospective study.

J A Mellor, J Kingdom, M Cafferkey

    The Journal of Antimicrobial Chemotherapy
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Optimal umbilical artery Doppler chart for predicting placenta-mediated fetal growth restriction.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2026
    Same author

    Clinical outcomes following implementation of diagnostic testing for pre-eclampsia within a UK tertiary hospital setting using angiogenic biomarkers.

    Pregnancy hypertension·2025
    Same author

    Safety and feasibility pilot study of continuous low-dose maternal supplemental oxygen in fetal single ventricle heart disease.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2024
    Same author

    ISUOG Practice Guidelines (updated): use of Doppler velocimetry in obstetrics.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
    Same author

    ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2020
    Same author

    Awareness and Preventative Behaviours Regarding Toxoplasma, Listeria and Cytomegalovirus Among Pregnant Women

    Irish medical journal·2019
    Same journal

    Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Re-evaluating the 14-day rule: short-course antifungal therapy for uncomplicated candidaemia in a multicentre cohort study.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Impact of selective digestive decontamination on the pangenome composition of ESBL-E. coli.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Compounds of the γ-carboline family inhibit trans-translation.

    The Journal of antimicrobial chemotherapy·2026
    See all related articles

    This study assessed vancomycin toxicity in 34 patients. Vancomycin showed minimal hearing loss and rare renal function decline, with no synergistic toxicity observed with aminoglycosides.

    Area of Science:

    • Pharmacology
    • Nephrology
    • Ototoxicology

    Background:

    • Intravenous vancomycin is a critical antibiotic for serious Gram-positive infections.
    • Assessing vancomycin's toxicity profile, especially in combination with other nephrotoxic agents like aminoglycosides, is crucial for patient safety.

    Purpose of the Study:

    • To evaluate the toxicity of intravenous vancomycin in a prospective patient cohort.
    • To specifically assess ototoxicity (hearing loss, tinnitus, dizziness) and nephrotoxicity (renal function decline).
    • To investigate potential synergistic toxicity between vancomycin and concurrent or sequential aminoglycoside administration.

    Main Methods:

    • Prospective study design involving 34 patients receiving 39 courses of intravenous vancomycin.
    • Categorization of vancomycin administration: alone or in combination with aminoglycosides.

    Related Experiment Videos

  • Monitoring for adverse events including hearing impairment and changes in renal function.

    • Main Results:

    • Hearing loss was infrequent and mild, with patients often unaware.
    • Two patients experienced transient tinnitus and dizziness, resolving upon vancomycin withdrawal.
    • Renal function deterioration occurred in 7% during and 9% after vancomycin therapy, often associated with severe underlying conditions.
    • No evidence of increased toxicity when vancomycin was combined with aminoglycosides.

    Conclusions:

    • Intravenous vancomycin exhibits a generally favorable toxicity profile regarding ototoxicity and nephrotoxicity in this cohort.
    • The severity of underlying illness appears to be a significant factor in vancomycin-associated renal function decline.
    • Vancomycin can be safely administered with aminoglycosides without apparent synergistic toxicity.